Piper Sandler analyst Matt O’Brien raised the firm’s price target on CVRx (CVRX) to $16 from $13 and keeps an Overweight rating on the shares. The firm notes CVRx released Q3 results that beat its target on the top-line and fell within management’s guidance range. Full-year guidance was narrowed with the mid-point coming down just a bit and seems achievable to Piper based on continued business momentum through October.